Frontlight ResearchEarly access
Trial site
Stanford Byers Eye Institute
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Graves' disease3 trials
- Diabetic eye disease2 trials
- Mitochondrial disease1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Viridian Therapeutics, Inc.3 trials
- Kodiak Sciences Inc2 trials
- Neurophth Therapeutics Inc1 trial
- Oculis1 trial
- Vantage Biosciences Ltd1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Active, not recruiting
Closed trials
Completed
Completed
Completed
An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026